BR9805135A - ilato sintase de neospora. - Google Patents

ilato sintase de neospora.

Info

Publication number
BR9805135A
BR9805135A BR9805135A BR9805135A BR9805135A BR 9805135 A BR9805135 A BR 9805135A BR 9805135 A BR9805135 A BR 9805135A BR 9805135 A BR9805135 A BR 9805135A BR 9805135 A BR9805135 A BR 9805135A
Authority
BR
Brazil
Prior art keywords
neospora
synthase
ilate
present
useful
Prior art date
Application number
BR9805135A
Other languages
English (en)
Inventor
Balakrishnan Rajendra Krishnan
Becky Ann Durtschi
Susan Christine Yoder
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of BR9805135A publication Critical patent/BR9805135A/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/0004—Oxidoreductases (1.)
    • C12N9/0012—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7)
    • C12N9/0026—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on CH-NH groups of donors (1.5)
    • C12N9/0028—Oxidoreductases (1.) acting on nitrogen containing compounds as donors (1.4, 1.5, 1.6, 1.7) acting on CH-NH groups of donors (1.5) with NAD or NADP as acceptor (1.5.1)
    • C12N9/003—Dihydrofolate reductase [DHFR] (1.5.1.3)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/1003—Transferases (2.) transferring one-carbon groups (2.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Toxicology (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

FOLATO REDUTASE DE TIMIDILATO SINTASE DE NEOSPORA"<D>. A presente invenção proporciona moléculas de pora, estas moléculas de polinucleotídeos são úteis na preparação de vacinas vivas modificadas contra a neoporose e como reagentes de diagnósticos. A presente invenção proporciona ainda vetores de cloas, proteínas DHFR-TS substancialmente purificadas úteis para a deleção dirigida de genes e composições de vacina.
BR9805135A 1997-12-04 1998-12-03 ilato sintase de neospora. BR9805135A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6750797P 1997-12-04 1997-12-04
US9521398P 1998-08-03 1998-08-03

Publications (1)

Publication Number Publication Date
BR9805135A true BR9805135A (pt) 2000-03-21

Family

ID=26747942

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9805135A BR9805135A (pt) 1997-12-04 1998-12-03 ilato sintase de neospora.

Country Status (9)

Country Link
US (1) US6436410B1 (pt)
EP (1) EP0924295A3 (pt)
JP (1) JP3245398B2 (pt)
CN (1) CN1225945A (pt)
AR (1) AR017709A1 (pt)
AU (1) AU738142B2 (pt)
BR (1) BR9805135A (pt)
CA (1) CA2253011A1 (pt)
NZ (1) NZ333160A (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA011578B1 (ru) * 2002-08-26 2009-04-28 Пфайзер Продактс Инк. Иммуногенная композиция для защиты крупного рогатого скота от инфекций респираторной и репродуктивной систем и ее применение
ES2263317B2 (es) * 2003-12-04 2007-10-01 Universidad Complutense De Madrid Uso del gen ncsag4 para el diagnostico y prevencion de la neosporosis, y como marcador para el analisis de la patogenia.
CN117305261B (zh) * 2023-11-30 2024-02-23 北京智源人工智能研究院 一种二氢叶酸还原酶纽结及其突变体

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5643718A (en) 1993-11-04 1997-07-01 The Board Of Trustees Of The Leland Stanford Junior University Transfection and genetic manipulations in obligate intracellular parasites
US5707617A (en) 1994-03-21 1998-01-13 The Regents Of The University Of California Bovine neospora isolates
US6743430B1 (en) * 1995-03-29 2004-06-01 Richard E. Parizek Multicomponent vaccine containing clostridial and non-clostridial organisms in a low dose
WO1997017082A1 (en) * 1995-11-09 1997-05-15 Trustees Of Dartmouth College A vaccine against toxoplasma gondii
US5795731A (en) * 1996-08-26 1998-08-18 Health Research Incorporated Inteins as antimicrobial targets: genetic screens for intein function
US5849564A (en) * 1996-11-29 1998-12-15 The Trustees Of Columbia University In The City Of New York Polypeptides from Kaposi's sarcoma-associated herpesvirus, DNA encoding same and uses thereof

Also Published As

Publication number Publication date
CN1225945A (zh) 1999-08-18
NZ333160A (en) 2000-06-23
JPH11266879A (ja) 1999-10-05
EP0924295A2 (en) 1999-06-23
EP0924295A3 (en) 2001-05-16
CA2253011A1 (en) 1999-06-04
AR017709A1 (es) 2001-09-12
JP3245398B2 (ja) 2002-01-15
US6436410B1 (en) 2002-08-20
AU738142B2 (en) 2001-09-13
AU9520598A (en) 1999-06-24

Similar Documents

Publication Publication Date Title
TR200102191T2 (tr) HER-2/neu füzyon proteinleri.
PL366826A1 (en) Reducing the immunogenicity of fusion proteins
DE69934242D1 (de) Polyketid synthase enzyme und rekombinante dna konstrukte dafür, zur herstellung von mit fk-506 und fk-520 verwandten verbindungen
AU6160201A (en) Human polypeptides causing or leading to the killing of cells including lymphoidtumor cells
CY1113379T1 (el) Πεπτιδια κdr και εμβολια που τα περιλαμβανουν
HK1038929A1 (en) Cancer antigens based on tumor suppressor gene wt1product.
WO2002012341A3 (en) Her-2/neu fusion proteins
BR9910089A (pt) Composições e antìgenos de neisseria meningitidis
MXPA01003557A (es) Secuencias genomicas de neisseria y metodos para su uso.
MY140539A (en) 1-amino 1h-imidazoquinolines
YU40701A (sh) Piperidini kao modulatori ccr5
PT1212358E (pt) Genes sinteticos de papilomavirus humano
NO20055209L (no) Peptabody for cancerbehandling
CY1117746T1 (el) Αντιγονα αιμοφιλου της γριπης και αντιστοιχα θραυσματα dna
CY1112195T1 (el) Μεθοδος παρασκευης ενος πεπτιδιου με pl πανω απο 8 ή κατω απο 5
SG167667A1 (en) Nucleic acid compositions for stimulating immune responses
BR9805135A (pt) ilato sintase de neospora.
BR0011469A (pt) Gm-csf equina
BR0110111A (pt) Derivados de ácido poliamidanucléico, agentes e processos para a sua preparação
DE69838324D1 (de) Ph-sensitive liposomen und andere typen immunomodulatoren enthaltender gekapselter impfstoffe sowie herstellungs- und anwendungsverfahren dafür
ATE346087T1 (de) Hepatitis e-virus aus dem schwein und dessen verwendungen
BR0112486A (pt) Poliproteìna, molécula de ácido nucleico, plasmìdeo, vacina recombinante ou vacina atenuada, composição farmacêutica, e, método para imunizar um indivìduo contra hiv
BR0002602A (pt) Vacina viva atenuada, uso de uma bactéria viva atenuada, e, processo para a preparação de uma vacina
BR0116704A (pt) Antìgenos de streptococcus pyogenes e fragmentos de dna correspondentes
WO2003090778A3 (en) Dna vaccine combined with an inducer of tumor cell apoptosis

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 5A, 6A, 7A E 8A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1872 DE 21/11/2006.